CA
NZ
UK
AU
IND
US
Keurig Dr Pepper Inc. filed a Form 8-K on August 12, 2026, disclosing that its Board of Directors appointed Aaron Alt as an independent director and expanded the board to ten members, both effective August 14, 2026.
Synopsys, Inc. filed a Form 8-K on August 12, 2026, disclosing that General Counsel and Corporate Secretary Janet Lee will depart her role no later than December 31, 2026, and will then serve in an advisory capacity through at least June 30, 2027.
Cardinal Infrastructure Group Inc. filed its quarterly report on Form 10-Q with the SEC on August 12, 2026, covering the fiscal quarter ended June 30, 2026, and reporting significant growth in revenues, assets, and equity compared to the prior year period.
CAVA Group, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the fiscal quarter ended July 12, 2026, reporting 116,806,198 shares of common stock outstanding as of August 4, 2026.
Alkermes Public Limited Company filed a Form 8-K on August 12, 2026, disclosing that it entered into Amendment No. 1 to its Credit Agreement, reducing interest rate spreads on two senior secured term loan facilities.
Enanta Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q with the SEC on August 12, 2026, covering the three- and nine-month periods ended June 30, 2026.
Liquidia Corporation (NASDAQ:LQDA) filed its Form 10-Q for the fiscal quarter ended June 30, 2026, with the U.S. Securities and Exchange Commission, reporting on its commercial operations, pipeline, and ongoing litigation as of that date.
Liquidia Corporation filed a current report on Form 8-K with the SEC on August 12, 2026, disclosing its financial results for the quarter ended June 30, 2026, and an updated corporate presentation.
Sutro Biopharma, Inc. (NASDAQ:STRO) filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 12, 2026, covering the period ended June 30, 2026.
Sutro Biopharma, Inc. filed a current report on August 12, 2026, announcing its financial results for the quarter ended June 30, 2026, and disclosing an updated corporate presentation under Regulation FD.
Please wait processing your request...